$342 Million is the total value of Parkman Healthcare Partners LLC's 80 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 40.5% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
IRTC | Buy | IRHYTHM TECHNOLOGIES INC | $16,374,000 | +124.5% | 103,981 | +67.8% | 4.79% | +197.8% |
UTHR | Sell | UNITED THERAPEUTICS CORP DEL | $13,296,000 | -31.8% | 74,107 | -17.8% | 3.89% | -9.5% |
UNH | Sell | UNITEDHEALTH GROUP INC | $12,916,000 | -32.0% | 25,327 | -33.0% | 3.78% | -9.8% |
SGEN | Buy | SEAGEN INC | $12,402,000 | -0.7% | 86,096 | +6.6% | 3.63% | +31.7% |
IMUX | Buy | IMMUNIC INC | $12,309,000 | +32.0% | 1,089,251 | +11.8% | 3.60% | +75.1% |
THC | Buy | TENET HEALTHCARE CORP | $11,964,000 | +266.1% | 139,185 | +248.0% | 3.50% | +385.6% |
IQV | Sell | IQVIA HLDGS INC | $11,581,000 | -43.9% | 50,090 | -31.5% | 3.39% | -25.5% |
ACRS | Sell | ACLARIS THERAPEUTICS INC | $11,518,000 | -22.8% | 668,098 | -34.9% | 3.37% | +2.5% |
DHR | Sell | DANAHER CORPORATION | $10,845,000 | -44.0% | 36,972 | -37.2% | 3.17% | -25.7% |
XENE | Sell | XENON PHARMACEUTICALS INC | $9,299,000 | -17.4% | 304,186 | -15.6% | 2.72% | +9.5% |
RCM | Buy | R1 RCM INC | $9,177,000 | +19.9% | 342,923 | +14.2% | 2.69% | +58.9% |
ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $8,819,000 | -9.8% | 54,008 | -6.4% | 2.58% | +19.5% |
CTLT | Buy | CATALENT INC | $8,767,000 | +12.4% | 79,049 | +29.7% | 2.57% | +49.0% |
CVS | Sell | CVS HEALTH CORP | $8,665,000 | -37.0% | 85,618 | -35.8% | 2.54% | -16.4% |
CDMO | Buy | AVID BIOSERVICES INC | $8,300,000 | -1.9% | 407,458 | +40.5% | 2.43% | +30.1% |
COO | Sell | COOPER COS INC | $8,179,000 | -17.7% | 19,585 | -17.4% | 2.39% | +9.2% |
BCRX | Buy | BIOCRYST PHARMACEUTICALS INC | $7,756,000 | +40.0% | 476,978 | +19.2% | 2.27% | +85.8% |
ABBV | Sell | ABBVIE INC | $7,413,000 | +5.9% | 45,731 | -11.6% | 2.17% | +40.4% |
DXCM | Sell | DEXCOM INC | $6,516,000 | -63.1% | 12,737 | -61.3% | 1.91% | -51.1% |
NBIX | New | NEUROCRINE BIOSCIENCES INC | $5,928,000 | – | 63,234 | +100.0% | 1.74% | – |
CDXS | Sell | CODEXIS INC | $5,529,000 | -48.0% | 268,144 | -21.2% | 1.62% | -31.1% |
AVTR | Sell | AVANTOR INC | $5,356,000 | -68.8% | 158,365 | -61.1% | 1.57% | -58.7% |
NTRA | Buy | NATERA INC | $5,286,000 | -54.6% | 129,944 | +4.3% | 1.55% | -39.7% |
RCUS | Buy | ARCUS BIOSCIENCES INC | $5,281,000 | +11.4% | 167,321 | +42.9% | 1.55% | +47.8% |
ATEC | Buy | ALPHATEC HLDGS INC | $5,196,000 | +93.5% | 451,794 | +92.3% | 1.52% | +156.9% |
IDXX | Sell | IDEXX LABS INC | $5,136,000 | -28.9% | 9,388 | -14.4% | 1.50% | -5.7% |
APEN | Sell | APOLLO ENDOSURGERY INC | $4,903,000 | -36.7% | 810,411 | -11.8% | 1.44% | -16.0% |
SRRA | New | SIERRA ONCOLOGY INC | $4,869,000 | – | 151,915 | +100.0% | 1.42% | – |
TFX | New | TELEFLEX INCORPORATED | $4,435,000 | – | 12,500 | +100.0% | 1.30% | – |
LEGN | New | LEGEND BIOTECH CORPsponsored ads | $4,378,000 | – | 120,473 | +100.0% | 1.28% | – |
SDGR | Buy | SCHRODINGER INC | $3,954,000 | +67.5% | 115,891 | +71.0% | 1.16% | +122.1% |
KROS | Buy | KEROS THERAPEUTICS INC | $3,953,000 | -3.3% | 72,690 | +4.0% | 1.16% | +28.3% |
HBIO | Buy | HARVARD BIOSCIENCE INC | $3,936,000 | +4.0% | 633,826 | +18.0% | 1.15% | +38.0% |
FULC | Sell | FULCRUM THERAPEUTICS INC | $3,889,000 | -12.1% | 164,453 | -34.2% | 1.14% | +16.6% |
OM | Buy | OUTSET MED INC | $3,705,000 | +69.9% | 81,601 | +72.5% | 1.08% | +125.4% |
SUPN | Buy | SUPERNUS PHARMACEUTICALS INC | $3,521,000 | +15.3% | 108,954 | +4.0% | 1.03% | +52.8% |
PODD | Sell | INSULET CORP | $3,375,000 | -25.4% | 12,671 | -25.5% | 0.99% | -1.0% |
MASS | New | 908 DEVICES INC | $3,327,000 | – | 175,000 | +100.0% | 0.97% | – |
ANIP | Sell | ANI PHARMACEUTICALS INC | $3,033,000 | -52.0% | 107,911 | -21.4% | 0.89% | -36.3% |
PFMT | Buy | PERFORMANT FINL CORP | $2,977,000 | +45.3% | 957,083 | +12.6% | 0.87% | +92.7% |
CRL | Sell | CHARLES RIV LABS INTL INC | $2,840,000 | -70.9% | 10,000 | -61.4% | 0.83% | -61.4% |
MRVI | Sell | MARAVAI LIFESCIENCES HLDGS I | $2,730,000 | -34.0% | 77,389 | -21.6% | 0.80% | -12.4% |
Buy | IMAGO BIOSCIENCES INC | $2,693,000 | +3.3% | 139,751 | +27.0% | 0.79% | +37.0% | |
BCYC | Sell | BICYCLE THERAPEUTICS PLCsponsored ads | $2,514,000 | -36.3% | 57,295 | -11.6% | 0.74% | -15.4% |
MNKD | Buy | MANNKIND CORP | $2,485,000 | +113.9% | 675,403 | +154.0% | 0.73% | +184.0% |
HCAT | Buy | HEALTH CATALYST INC | $2,084,000 | -0.1% | 79,746 | +51.4% | 0.61% | +32.3% |
MDGL | Sell | MADRIGAL PHARMACEUTICALS INC | $1,985,000 | -18.3% | 20,230 | -29.4% | 0.58% | +8.4% |
KRMD | Buy | REPRO MED SYS INC | $1,923,000 | +7.3% | 672,457 | +12.5% | 0.56% | +42.2% |
ALT | Buy | ALTIMMUNE INC | $1,885,000 | -21.9% | 309,586 | +17.5% | 0.55% | +3.8% |
GOSS | Sell | GOSSAMER BIO INC | $1,738,000 | -71.9% | 200,185 | -63.4% | 0.51% | -62.7% |
VCYT | Sell | VERACYTE INC | $1,672,000 | -34.8% | 60,651 | -2.6% | 0.49% | -13.6% |
ATRC | New | ATRICURE INC | $1,657,000 | – | 25,236 | +100.0% | 0.48% | – |
AKYA | Buy | AKOYA BIOSCIENCES INC | $1,652,000 | -13.7% | 150,321 | +20.3% | 0.48% | +14.5% |
TKNO | Buy | ALPHA TEKNOVA INC | $1,650,000 | -23.4% | 119,468 | +13.6% | 0.48% | +1.5% |
STRO | Sell | SUTRO BIOPHARMA INC | $1,643,000 | -50.1% | 199,846 | -9.7% | 0.48% | -33.7% |
PSTV | New | PLUS THERAPEUTICS INC | $1,526,000 | – | 1,526,316 | +100.0% | 0.45% | – |
LNTH | New | LANTHEUS HLDGS INC | $1,399,000 | – | 25,295 | +100.0% | 0.41% | – |
LNDC | New | LANDEC CORP | $1,335,000 | – | 115,316 | +100.0% | 0.39% | – |
CNCE | New | CONCERT PHARMACEUTICALS INC | $1,272,000 | – | 377,399 | +100.0% | 0.37% | – |
TELA | Buy | TELA BIO INC | $1,262,000 | -5.5% | 108,504 | +4.0% | 0.37% | +25.1% |
MRTX | Buy | MIRATI THERAPEUTICS INC | $1,253,000 | -33.8% | 15,236 | +18.0% | 0.37% | -12.2% |
REPH | Buy | SOCIETAL CDMO INC | $1,209,000 | +9.5% | 671,817 | +4.0% | 0.35% | +45.1% |
SIEN | Buy | SIENTRA INC | $1,181,000 | -34.6% | 531,860 | +8.2% | 0.35% | -13.1% |
KNSA | Buy | KINIKSA PHARMACEUTICALS LTD | $1,175,000 | -12.2% | 118,247 | +4.1% | 0.34% | +16.6% |
FMTX | Buy | FORMA THERAPEUTICS HLDGS INC | $1,156,000 | -18.7% | 124,310 | +24.3% | 0.34% | +7.6% |
CTIC | New | CTI BIOPHARMA CORP | $1,051,000 | – | 225,000 | +100.0% | 0.31% | – |
AXGN | Sell | AXOGEN INC | $1,024,000 | -47.1% | 128,947 | -37.6% | 0.30% | -29.7% |
ANAB | Buy | ANAPTYSBIO INC | $922,000 | -25.9% | 37,285 | +4.1% | 0.27% | -1.8% |
PHAT | Sell | PHATHOM PHARMACEUTICALS INC | $892,000 | -41.5% | 65,553 | -15.4% | 0.26% | -22.3% |
ALLK | New | ALLAKOS INC | $867,000 | – | 152,066 | +100.0% | 0.25% | – |
ZYME | Buy | ZYMEWORKS INC | $781,000 | +14.5% | 119,286 | +186.6% | 0.23% | +52.7% |
OPNT | Buy | OPIANT PHARMACEUTICALS INC | $697,000 | -33.7% | 32,557 | +4.0% | 0.20% | -12.1% |
MIRM | New | MIRUM PHARMACEUTICALS INC | $668,000 | – | 30,354 | +100.0% | 0.20% | – |
SURF | Sell | SURFACE ONCOLOGY INC | $615,000 | -50.3% | 209,148 | -19.2% | 0.18% | -34.1% |
BLRX | Sell | BIOLINERX LTDsponsored ads | $463,000 | -47.0% | 270,665 | -36.9% | 0.14% | -29.5% |
EIGR | New | EIGER BIOPHARMACEUTICALS INC | $415,000 | – | 50,000 | +100.0% | 0.12% | – |
RCKT | New | ROCKET PHARMACEUTICALS INC | $401,000 | – | 25,295 | +100.0% | 0.12% | – |
MTEM | Sell | MOLECULAR TEMPLATES INC | $358,000 | -38.2% | 103,709 | -29.8% | 0.10% | -18.0% |
NRIX | Sell | NURIX THERAPEUTICS INC | $289,000 | -88.6% | 20,663 | -76.5% | 0.08% | -84.8% |
VSTM | Buy | VERASTEM INC | $269,000 | -28.5% | 190,755 | +4.0% | 0.08% | -4.8% |
VERA | Exit | VERA THERAPEUTICS INCcl a | $0 | – | -21,555 | -100.0% | -0.13% | – |
ONCT | Exit | ONCTERNAL THERAPEUTICS INC | $0 | – | -289,280 | -100.0% | -0.14% | – |
ICAD | Exit | ICAD INC | $0 | – | -103,302 | -100.0% | -0.16% | – |
QTRX | Exit | QUANTERIX CORP | $0 | – | -20,000 | -100.0% | -0.19% | – |
CSLT | Exit | CASTLIGHT HEALTH INCcl b | $0 | – | -625,678 | -100.0% | -0.21% | – |
Exit | RAPID MICRO BIOSYSTEMS INC | $0 | – | -100,000 | -100.0% | -0.24% | – | |
HALO | Exit | HALOZYME THERAPEUTICS INC | $0 | – | -41,333 | -100.0% | -0.37% | – |
SMLR | Exit | SEMLER SCIENTIFIC INC | $0 | – | -21,419 | -100.0% | -0.43% | – |
ETNB | Exit | 89BIO INC | $0 | – | -152,098 | -100.0% | -0.44% | – |
ANGO | Exit | ANGIODYNAMICS INC | $0 | – | -87,969 | -100.0% | -0.54% | – |
IONS | Exit | IONIS PHARMACEUTICALS INC | $0 | – | -80,238 | -100.0% | -0.54% | – |
STXS | Exit | STEREOTAXIS INC | $0 | – | -413,218 | -100.0% | -0.56% | – |
RGEN | Exit | REPLIGEN CORP | $0 | – | -10,331 | -100.0% | -0.60% | – |
KOD | Exit | KODIAK SCIENCES INC | $0 | – | -35,174 | -100.0% | -0.66% | – |
BRKS | Exit | AZENTA INC | $0 | – | -36,554 | -100.0% | -0.83% | – |
XRAY | Exit | DENTSPLY SIRONA INC | $0 | – | -73,566 | -100.0% | -0.91% | – |
HZNP | Exit | HORIZON THERAPEUTICS PUB L | $0 | – | -100,747 | -100.0% | -2.40% | – |
XBI | Exit | SPDR SER TRcall | $0 | – | -100,000 | -100.0% | -2.47% | – |
HCA | Exit | HCA HEALTHCARE INC | $0 | – | -50,661 | -100.0% | -2.87% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-13
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
DEXCOM INC | 16 | Q3 2023 | 6.3% |
ACLARIS THERAPEUTICS INC | 16 | Q3 2023 | 10.0% |
XENON PHARMACEUTICALS INC | 16 | Q3 2023 | 3.3% |
NATERA INC | 16 | Q3 2023 | 3.4% |
AVID BIOSERVICES INC | 15 | Q3 2023 | 2.9% |
SCHRODINGER INC | 15 | Q3 2023 | 4.2% |
REPRO MED SYS INC | 15 | Q2 2023 | 2.0% |
MANNKIND CORP | 15 | Q3 2023 | 1.6% |
IQVIA HLDGS INC | 14 | Q1 2023 | 4.6% |
INSULET CORP | 14 | Q3 2023 | 2.9% |
View Parkman Healthcare Partners LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
PLUS THERAPEUTICS, INC. | February 13, 2023 | 583,467 | 1.7% |
View Parkman Healthcare Partners LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-11 |
13F-HR | 2023-05-12 |
SC 13G/A | 2023-02-13 |
13F-HR | 2023-02-13 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-12 |
13F-HR | 2022-05-13 |
13F-HR | 2022-02-11 |
View Parkman Healthcare Partners LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.